A research collaboration with the Dana Farber Cancer Institute was initiated in 2013. CGI provided the collaborating doctor with genomic regions to be used to classify a robust number of specimens for outcome in chronic lymphocytic leukemia (CLL). The regions provided by CGI were determined using CGI’s MatBA®-CLL array. The collaborating doctor’s data and CGI’s data were combined for the clinical validation of a CLL outcome scheme.